DRUG DESIGN AND DEVELOPMENT: PRECLINICAL ASPECT
DRUG DESIGN AND DEVELOPMENT, PRECLINICAL ASPECT is intended to give propelled training to
enrolled individuals by preclinical parts of translational medicine and related research.
This program is intended to create specialists for the high-demand field of drug development. The
program is organized particularly for working experts who wish to take a couple of courses in
advantageous weekends or as an online course from distance.
After completing this course, the learners will get acquainted with the following:
- It gets ready people for jobs in preclinical and clinical issues and early stage production.
- It makes individual specialists in drug development and its usage.
- Good knowledge in developing novel drug and its understanding at gene level
COURSE OUTLINE Module 1 – An introductory course
Module 2 – Detailed learning of drug design and development.
Module 3 – Overview of the translational medicine
Module 4 – Preclinical aspect of drug development
Module 6 – Conclusion
Certification Exam/ Assessment
M. Pharma and D. Pharma students
Duration: 6 Months
ABOUT THE AUTHOR
CELNET (Consortium e-Learning Network Private Limited) is an education empowerment
organization committed to equip the students with the right tools and resources to augment and utilize
knowledge to its full potential. CELNET is among the fastest growing and innovative publishers of journals
and now proud to introduce web-based training programs.